Stay updated with breaking news from Third Harmonic Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Third Harmonic Bio, Inc. (NASDAQ: THRD) shares cleared breakeven Tuesday, as the biopharmaceutical company focused on advancing the next wave of medicine for inflammatory diseases, today reported financial results for the fourth quarter ended December ...
NEW YORK, Feb. 22, 2024 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating Third Harmonic Bio, Inc. on behalf of the company's shareholders. The investigation seeks to...
/PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating Third Harmonic Bio, Inc. (NASDAQ: THRD) on behalf of the company's shareholders. The...
By Dean Seal Third Harmonic Bio has hired a former group vice president at Horizon Therapeutics to be its next chief financial officer. The biopharmaceutical...